Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 2
1999 3
2001 2
2002 2
2003 3
2004 4
2005 5
2006 3
2007 11
2008 15
2009 26
2010 28
2011 37
2012 40
2013 53
2014 76
2015 83
2016 110
2017 106
2018 115
2019 168
2020 215
2021 241
2022 240
2023 206
2024 220
2025 286
2026 169

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,135 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?
Uludag G, Hassan M, Matsumiya W, Pham BH, Chea S, Trong Tuong Than N, Doan HL, Akhavanrezayat A, Halim MS, Do DV, Nguyen QD. Uludag G, et al. Expert Opin Biol Ther. 2022 Oct;22(10):1275-1291. doi: 10.1080/14712598.2022.2100694. Epub 2022 Jul 17. Expert Opin Biol Ther. 2022. PMID: 35818801 Free PMC article. Review.
INTRODUCTION: Diabetic retinopathy (DR) is one of the most frequent microvascular complications of diabetes that can lead to blindness. Laser treatment has been the gold standard treatment for diabetic macular edema (DME) and proliferative diabetic …
INTRODUCTION: Diabetic retinopathy (DR) is one of the most frequent microvascular complications of diabetes that can lead to b …
Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: A review.
Tan Y, Fukutomi A, Sun MT, Durkin S, Gilhotra J, Chan WO. Tan Y, et al. Surv Ophthalmol. 2021 Nov-Dec;66(6):926-932. doi: 10.1016/j.survophthal.2021.03.001. Epub 2021 Mar 8. Surv Ophthalmol. 2021. PMID: 33705807 Review.
Anti-vascular endothelial growth factor (anti-VEGF) crunch syndrome describes the progression to tractional retinal detachment following intravitreal anti-VEGF therapy in an eye with proliferative diabetic retinopathy . ...Risk factors fo …
Anti-vascular endothelial growth factor (anti-VEGF) crunch syndrome describes the progression to tractional retinal detachment …
Diabetic Retinopathy: Pathophysiology and Treatments.
Wang W, Lo ACY. Wang W, et al. Int J Mol Sci. 2018 Jun 20;19(6):1816. doi: 10.3390/ijms19061816. Int J Mol Sci. 2018. PMID: 29925789 Free PMC article. Review.
Diabetic retinopathy (DR) is the most common complication of diabetes mellitus (DM). It has long been recognized as a microvascular disease. ...Laboratory and clinical evidence showed that in addition to microvascular changes, inflammation and retinal neurodegenerat …
Diabetic retinopathy (DR) is the most common complication of diabetes mellitus (DM). It has long been recognized as a microvas …
Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies.
Seo H, Park SJ, Song M. Seo H, et al. Cells. 2025 Mar 4;14(5):376. doi: 10.3390/cells14050376. Cells. 2025. PMID: 40072104 Free PMC article. Review.
Diabetic retinopathy (DR) is one of the most prevalent complications of diabetes, affecting nearly one-third of patients with diabetes mellitus and remaining a leading cause of blindness worldwide. ...Current gold standard therapies, such as anti-VEGF …
Diabetic retinopathy (DR) is one of the most prevalent complications of diabetes, affecting nearly one-third of patients with …
Diabetic retinopathy.
Wong TY, Cheung CM, Larsen M, Sharma S, Simó R. Wong TY, et al. Nat Rev Dis Primers. 2016 Mar 17;2:16012. doi: 10.1038/nrdp.2016.12. Nat Rev Dis Primers. 2016. PMID: 27159554 Review.
Diabetic retinopathy (DR) is a common complication of diabetes mellitus and is a major cause of vision loss in middle-aged and elderly people. ...Optimal control of blood glucose and blood pressure in individuals with diabetes remains the cornerstone for preventing …
Diabetic retinopathy (DR) is a common complication of diabetes mellitus and is a major cause of vision loss in middle-aged and …
VEGF in Diabetic Retinopathy and Age-Related Macular Degeneration.
Callan A, Heckman J, Tah G, Lopez S, Valdez L, Tsin A. Callan A, et al. Int J Mol Sci. 2025 May 22;26(11):4992. doi: 10.3390/ijms26114992. Int J Mol Sci. 2025. PMID: 40507802 Free PMC article. Review.
Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis throughout the human body, influencing countless physiological and pathological processes, including tumor growth, preeclampsia, and retinal diseases such as diabetic retinopathy (DR) and age …
Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis throughout the human body, influencing countless physiological an …
A Review on Diabetic Retinopathy.
Kour V, Swain J, Singh J, Singh H, Kour H. Kour V, et al. Curr Diabetes Rev. 2024;20(6):e201023222418. doi: 10.2174/0115733998253672231011161400. Curr Diabetes Rev. 2024. PMID: 37867267 Review.
Over the last decade, there have been advances in the diagnosis of diabetic retinopathy and diabetic macular edema. At the same time, newer therapies for the management of diabetic retinopathy have evolved. ...An effort has been made to review a …
Over the last decade, there have been advances in the diagnosis of diabetic retinopathy and diabetic macular edema. At …
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.
Simmonds M, Llewellyn A, Walker R, Fulbright H, Walton M, Hodgson R, Bojke L, Stewart L, Dias S, Rush T, Lawrenson JG, Peto T, Steel D. Simmonds M, et al. Health Technol Assess. 2024 Dec;29(23):1-71. doi: 10.3310/PCGV5709. Health Technol Assess. 2024. PMID: 39673354 Free PMC article.
BACKGROUND: Diabetic retinopathy is a major cause of sight loss in people with diabetes. The most severe form, proliferative diabetic retinopathy, carries a high risk of vision loss, vitreous haemorrhage, macular oedema and other harms. Panretinal phot …
BACKGROUND: Diabetic retinopathy is a major cause of sight loss in people with diabetes. The most severe form, proliferative …
VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy.
Arrigo A, Aragona E, Bandello F. Arrigo A, et al. Ann Med. 2022 Dec;54(1):1089-1111. doi: 10.1080/07853890.2022.2064541. Ann Med. 2022. PMID: 35451900 Free PMC article. Review.
Based on the current data, laser approaches might be avoided when a perfectly planned anti-VEGF therapeutic strategy can be adopted. Conversely, laser treatment may have a role for those patients unable to guarantee enough compliance to anti-VEGF injec …
Based on the current data, laser approaches might be avoided when a perfectly planned anti-VEGF therapeutic strategy can be ad …
Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy.
Chatziralli I, Touhami S, Cicinelli MV, Agapitou C, Dimitriou E, Theodossiadis G, Theodossiadis P. Chatziralli I, et al. Eye (Lond). 2022 Apr;36(4):692-703. doi: 10.1038/s41433-021-01750-4. Epub 2021 Aug 18. Eye (Lond). 2022. PMID: 34408316 Free PMC article. Review.
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus (DM) and the leading cause of blindness in patients with DM. ...Regarding peripheral ischemia, studies using wide-field-FFA demonstrated an improvement or stability in non-p …
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus (DM) and the leading cause of bli …
2,135 results